ArticleCancer science2015

Multitargeting strategy using lenvatinib and golvatinib: maximizing anti-angiogenesis activity in a preclinical cancer model.

Youya Nakazawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.